CLINICAL TRIALS PROFILE FOR FEXINIDAZOLE
✉ Email this page to a colleague
All Clinical Trials for fexinidazole
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00982904 ↗ | Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the Fexinidazole | Completed | Sanofi | Phase 1 | 2009-09-01 | This study is aimed at assessing the tolerability and pharmacokinetic parameters of the fexinidazole in healthy volunteers. In animal models of both acute and chronic experimental Trypanosomiasis infections, fexinidazole shows highly promising efficacy. |
NCT00982904 ↗ | Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the Fexinidazole | Completed | Drugs for Neglected Diseases | Phase 1 | 2009-09-01 | This study is aimed at assessing the tolerability and pharmacokinetic parameters of the fexinidazole in healthy volunteers. In animal models of both acute and chronic experimental Trypanosomiasis infections, fexinidazole shows highly promising efficacy. |
NCT01340157 ↗ | Fexinidazole (1200mg) Bioavailability Under Different Food Intake Conditions | Completed | Sanofi | Phase 1 | 2011-02-01 | The present study is designed to assess the impact of concomitant food intake on the relative bioavailability of a single oral fexinidazole tablet administration. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for fexinidazole
Condition Name
Clinical Trial Locations for fexinidazole
Clinical Trial Progress for fexinidazole
Clinical Trial Phase
Clinical Trial Sponsors for fexinidazole
Sponsor Name